Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Misonix, Inc.    MSON

MISONIX, INC.

(MSON)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/13/2020 02/14/2020 02/18/2020 02/19/2020 02/20/2020 Date
17.4(c) 17.16(c) 16.88(c) 17.21(c) 17.14(c) Last
44 894 62 171 54 849 127 286 69 280 Volume
-0.68% -1.38% -1.63% +1.95% -0.41% Change
More quotes
Financials (USD)
Sales 2020 72,5 M
EBIT 2020 -12,6 M
Net income 2020 -10,9 M
Debt 2020 -
Yield 2020 -
Sales 2021 95,8 M
EBIT 2021 -5,12 M
Net income 2021 -8,19 M
Debt 2021 -
Yield 2021 -
P/E ratio 2020 -23,3x
P/E ratio 2021 -37,0x
Capi. / Sales2020 4,10x
Capi. / Sales2021 3,11x
Capitalization 298 M
More Financials
Company
Misonix, Inc. (Misonix) is a medical devices company. Misonix is engaged in designing, manufacturing and marketing of minimally invasive therapeutic ultrasonic medical devices. Its products include BoneScalpel Surgical System (BoneScalpel), SonicOne Wound Cleansing and Debridement System (SonicOne)... 
More about the company
Surperformance© ratings of Misonix, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on MISONIX, INC.
02/18Misonix to Present at the 40th Annual Cowen Healthcare Conference on March 2
GL
02/05MISONIX : Fiscal 2Q Earnings Snapshot
AQ
02/05MISONIX : Management's Discussion and Analysis of Financial Condition and Result..
AQ
02/05MISONIX INC : Results of Operations and Financial Condition, Financial Statement..
AQ
02/05Misonix Reports Record Quarterly Revenue of $19.7 Million for Fiscal 2020 Sec..
GL
01/27Misonix to Report Fiscal 2020 Second Quarter Financial Results And Host Confe..
GL
01/27MISONIX INC : Entry into a Material Definitive Agreement, Financial Statements a..
AQ
01/23Misonix Announces Pricing of Public Offering of Common Stock
GL
01/22Misonix Announces Public Offering of Common Stock
GL
01/16MISONIX INC : Results of Operations and Financial Condition, Financial Statement..
AQ
01/13Misonix Reports Preliminary Fiscal 2020 Second Quarter Revenue of Approximate..
GL
2019MISONIX INC : Entry into a Material Definitive Agreement, Creation of a Direct F..
AQ
2019Misonix to Present at 38th Annual J.P. Morgan Healthcare Conference
GL
2019Misonix Announces Results of New Large Real-World Studies That Further Prove ..
GL
2019MISONIX INC : Changes in Registrant's Certifying Accountant, Financial Statement..
AQ
More news
News in other languages on MISONIX, INC.

- No features available -

More news
Sector news : Medical Equipment
02/20FISHER & PAYKEL HEALTHCARE : F&P Healthcare Raises Fiscal Year Earnings, Revenue..
DJ
02/20SMITH & NEPHEW : +Nephew forecasts sales growth after best year since 2010
RE
02/18MEDTRONIC : Raises 2020 Guidance, Sets 4Q Outlook
DJ
02/18MEDTRONIC : 3Q Profit, Sales Rise
DJ
02/1421 States Reject $18 Billion Offer From Drug Wholesalers to Settle Opioid Lit..
DJ
More sector news : Medical Equipment
Chart MISONIX, INC.
Duration : Period :
Misonix, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MISONIX, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Average target price 28,33  $
Last Close Price 17,14  $
Spread / Highest target 75,0%
Spread / Average Target 65,3%
Spread / Lowest Target 57,5%
EPS Revisions
Managers
NameTitle
Stavros G. Vizirgianakis President, Chief Executive Officer & Director
Paul Arthur LaViolette Chairman
Sharon W. Klugewicz Chief Operating Officer
Joseph P. Dwyer Chief Financial Officer, Secretary & Treasurer
Daniel Voic VP-Engineering, Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
MISONIX, INC.-7.52%298
ABBOTT LABORATORIES2.88%158 029
MASIMO CORPORATION15.29%9 770
NOVOCURE LIMITED10.29%9 476
PENUMBRA, INC.16.36%6 765
ASAHI INTECC CO., LTD.-10.30%6 392